The India Helicobacter Pylori Test Market continues to gain momentum as gastric cancer screening programs and high-risk population identification create new testing paradigms. With gastric cancer representing a significant malignancy burden in India and H. pylori recognized as a Class I carcinogen, targeted screening of first-degree relatives and high-prevalence communities is gaining clinical...